HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Jürgen Goldschmidt Selected Research
Jürgen Goldschmidt Research Topics
Disease
2
Thrombosis (Thrombus)
10/2018 - 03/2011
2
Neoplasms (Cancer)
10/2018 - 01/2017
1
Alzheimer Disease (Alzheimer's Disease)
01/2023
1
Cognitive Dysfunction
01/2023
1
Deafness (Deaf Mutism)
06/2021
1
Venous Thrombosis (Deep-Vein Thrombosis)
10/2018
1
Blindness (Hysterical Blindness)
04/2018
1
Hearing Loss (Hearing Impairment)
04/2018
1
Synesthesia
04/2018
1
Paralysis (Palsy)
04/2018
1
Seizures (Absence Seizure)
12/2017
1
Carcinoma (Carcinomatosis)
01/2017
1
Body Weight (Weight, Body)
11/2016
1
Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome)
01/2014
1
Brain Ischemia (Cerebral Ischemia)
01/2014
1
Cysts
01/2012
1
Carotid Artery Thrombosis
03/2011
Drug/Important Bio-Agent (IBA)
2
Thallium
IBA
01/2014 - 01/2012
1
nitarsone
IBA
01/2023
1
Amyloid (Amyloid Fibrils)
IBA
01/2023
1
Peptides (Polypeptides)
IBA
01/2023
1
Plasma Membrane Calcium-Transporting ATPases
IBA
06/2021
1
Immunoglobulins (Immunoglobulin)
IBA
06/2021
1
Antibodies
IBA
10/2018
1
Integrins
IBA
10/2018
1
Pentylenetetrazole (Metrazol)
IBA
12/2017
1
Therapeutic Uses
IBA
01/2017
1
Neurotensin Receptors (Neurotensin Receptor)
IBA
01/2017
1
Estrogens (Estrogen)
FDA Link
11/2016
1
Glucagon-Like Peptide 1 (GLP 1)
IBA
11/2016
1
Proteins (Proteins, Gene)
FDA Link
01/2012
1
Antigens
IBA
01/2012
1
Potassium
IBA
01/2012
1
Ligands
IBA
03/2011
1
Epitopes
IBA
03/2011
Therapy/Procedure
1
Therapeutics
04/2018